Diabetes 53:645-653, 2004
© 2004 by the American Diabetes Association, Inc.
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin
Clinical Pathophysiology and Natural History of ß-Cell Dysfunction and Insulin Resistance
Franck Mauvais-Jarvis1,
Eugène Sobngwi1,
Raphaël Porcher2,
Jean-Pierre Riveline3,
Jean-Philippe Kevorkian4,
Christian Vaisse5,
Guillaume Charpentier3,
Pierre-Jean Guillausseau4,
Patrick Vexiau1, and
Jean-François Gautier1
1 Department of Endocrinology & Diabetes, Saint-Louis Hospital and University of Paris VII School of Medicine, Paris, France
2 Department of Medical Biostatistics, Saint-Louis Hospital and University of Paris VII School of Medicine, Paris, France
3 Department of Diabetes and Metabolic Diseases, Sud Francilien Hospital, Corbeil-Essonnes, France
4 Department of Internal Medicine B, Lariboisiere Hospital, Paris, France
5 Diabetes Research Center, Department of Medicine, University of California San Francisco, San Francisco, California
Nonautoimmune ketosis-prone diabetic syndromes are increasingly frequent in nonwhite populations. We have characterized a cohort of patients of sub-Saharan African origin who had ketosis-prone type 2 diabetes (n = 111), type 1 diabetes (n = 21), and type 2 diabetes (n = 88) and were admitted to a hospital for management of uncontrolled diabetes. We compared epidemiological, clinical, and metabolic features at diabetes onset and measured insulin secretion (glucagon-stimulated C-peptide) and insulin action (short intravenous insulin tolerance test) during a 10-year follow-up. Ketosis-prone type 2 diabetes shows a strong male predominance, stronger family history, higher age and BMI, and more severe metabolic decompensation than type 1 diabetes. In ketosis-prone type 2 diabetes, discontinuation of insulin therapy with development of remission of insulin dependence is achieved in 76% of patients (noninsulin dependent), whereas only 24% of patients remain insulin dependent. During evolution, ketosis-prone type 2 diabetes exhibit specific ß-cell dysfunction features that distinguish it from type 1 and type 2 diabetes. The clinical course of noninsulin-dependent ketosis-prone type 2 diabetes is characterized by ketotic relapses followed or not by a new remission. Progressive hyperglycemia precedes and is a strong risk factor for ketotic relapses (hazard ratio 38). The probability for noninsulin-dependent ketosis-prone type 2 diabetes to relapse is 90% within 10 years, of whom 50% will become definitively insulin dependent. Insulin sensitivity is decreased in equal proportion in both ketosis-prone type 2 diabetes and type 2 diabetes, but improves significantly in noninsulin-dependent ketosis-prone type 2 diabetes, only after correction of hyperglycemia. In conclusion, ketosis-prone type 2 diabetes can be distinguished from type 1 diabetes and classical type 2 diabetes by specific features of clinical pathophysiology and also by the natural history of ß-cell dysfunction and insulin resistance reflecting a propensity to glucose toxicity.
Address correspondence and reprint requests to Franck Mauvais-Jarvis, MD, Department of Medicine, Division of Diabetes, Endocrinology & Metabolism, Baylor College of Medicine, One Baylor Plaza, 520B Houston, TX 77030. E-mail: fmjarvis{at}bcm.tmc.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Sobngwi, S. P. Choukem, F. Agbalika, B. Blondeau, L.-S. Fetita, C. Lebbe, D. Thiam, P. Cattan, J. Larghero, F. Foufelle, et al.
Ketosis-Prone Type 2 Diabetes Mellitus and Human Herpesvirus 8 Infection in Sub-Saharan Africans
JAMA,
June 18, 2008;
299(23):
2770 - 2776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Windus, J. H. Ladenson, C. K. Merrins, M. Seyoum, D. Windus, S. Morin, B. Tewelde, C. A. Parvin, M. G. Scott, and J. Goldfeder
Impact of a Multidisciplinary Intervention for Diabetes in Eritrea
Clin. Chem.,
November 1, 2007;
53(11):
1954 - 1959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Balasubramanyam, G. Garza, L. Rodriguez, C. S. Hampe, L. Gaur, A. Lernmark, and M. R. Maldonado
Accuracy and Predictive Value of Classification Schemes for Ketosis-Prone Diabetes
Diabetes Care,
December 1, 2006;
29(12):
2575 - 2579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Kitabchi, G. E. Umpierrez, M. B. Murphy, and R. A. Kreisberg
Hyperglycemic Crises in Adult Patients With Diabetes: A consensus statement from the American Diabetes Association
Diabetes Care,
December 1, 2006;
29(12):
2739 - 2748.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Umpierrez
Ketosis-Prone Type 2 Diabetes: Time to revise the classification of diabetes
Diabetes Care,
December 1, 2006;
29(12):
2755 - 2757.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sze, D. Gould, G. Hitman, and T. A Chowdhury
Relapsing and remitting insulin requiring diabetes: type 1 or type 2?
J R Soc Med,
August 1, 2006;
99(8):
415 - 416.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Le May, K. Chu, M. Hu, C. S. Ortega, E. R. Simpson, K. S. Korach, M.-J. Tsai, and F. Mauvais-Jarvis
Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice
PNAS,
June 13, 2006;
103(24):
9232 - 9237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Umpierrez, D. Smiley, and A. E. Kitabchi
Narrative review: ketosis-prone type 2 diabetes mellitus.
Ann Intern Med,
March 7, 2006;
144(5):
350 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Beran, J. S. Yudkin, and M. de Courten
Access to Care for Patients With Insulin-Requiring Diabetes in Developing Countries: Case studies of Mozambique and Zambia
Diabetes Care,
September 1, 2005;
28(9):
2136 - 2140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sobngwi, J.-F. Gautier, J.-P. Kevorkian, J.-M. Villette, J.-P. Riveline, S. Zhang, P. Vexiau, S. M. Leal, C. Vaisse, and F. Mauvais-Jarvis
High Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency without Gene Mutation Suggests a Novel Genetic Mechanism Predisposing to Ketosis-Prone Diabetes
J. Clin. Endocrinol. Metab.,
August 1, 2005;
90(8):
4446 - 4451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mauvais-Jarvis, S. B. Smith, C. L. May, S. M. Leal, J.-F. Gautier, M. Molokhia, J.-P. Riveline, A. S. Rajan, J.-P. Kevorkian, S. Zhang, et al.
PAX4 gene variations predispose to ketosis-prone diabetes
Hum. Mol. Genet.,
December 15, 2004;
13(24):
3151 - 3159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rasouli and S. C. Elbein
Improved Glycemic Control in Subjects with Atypical Diabetes Results from Restored Insulin Secretion, But Not Improved Insulin Sensitivity
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6331 - 6335.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|